Metraipolis › archive › dc_6aa6e4cf4e0d

Comparative efficacy and safety of second-line therapies for patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis of… — Europe PMC PMID:41357874

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41357874
DOI
10.3389/fphar.2025.1697949
License (as archived)
solo-consultazione
Archived
2026-11-08T09:59:36.711Z
SHA-256 of the archived text
6018ae366cb8dbf4e937ff29784ce182e85a72a29c6c47b82d0105f18468dcc4
Stable URL of this page
https://metraipolis.com/documento/dc_6aa6e4cf4e0d

How to cite

Comparative efficacy and safety of second-line therapies for patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis of… — Europe PMC PMID:41357874 — Europe PMC (en), https://europepmc.org/article/MED/41357874 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_6aa6e4cf4e0d (Metraipolis archive dc_6aa6e4cf4e0d, sha256 6018ae366cb8dbf4e937ff29784ce182e85a72a29c6c47b82d0105f18468dcc4)
BibTeX
@misc{dc6aa6e4cf4e0d,
  title = {Comparative efficacy and safety of second-line therapies for patients with advanced hepatocellular carcinoma: a systematic review and network meta-analysis of… — Europe PMC PMID:41357874},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41357874},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_6aa6e4cf4e0d; sha256 6018ae366cb8dbf4e937ff29784ce182e85a72a29c6c47b82d0105f18468dcc4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41357874. Agents can read the archived copy with the MCP tool read_document.